Related Experiment Video
Updated: Aug 6, 2026

Inducible and Reversible Dominant-negative (DN) Protein Inhibition
Published on: January 7, 2019
A new class of retinoids with selective inhibition of AP-1 inhibits proliferation
A Fanjul1, M I Dawson, P D Hobbs
1Cancer Center, La Jolla Cancer Research Foundation, La Jolla, California 92037.
Abstract:
Retinoids regulate many biological processes, including differentiation, morphogenesis and cell proliferation. They are also important therapeutic agents, but their clinical usefulness is limited because of side effects. Retinoid activities are mediated by specific nuclear receptors, the RARs and RXRs, which can induce transcriptional activation through specific DNA sites or by inhibiting the transcription factor AP-1 (refs 12-15), which usually mediates cell proliferation signals. Because the two types of receptor actions are mechanistically distinct, we investigated whether conformationally restricted retinoids, selective for each type of receptor action, could be identified. Here we describe a new class of retinoids that selectively inhibits AP-1 activity but does not activate transcription. These retinoids do not induce differentiation in F9 cells but inhibit effectively the proliferation of several tumour cell lines, and could thus serve as candidates for new retinoid therapeutic agents with reduced side effects.
Insights
New retinoids selectively inhibit AP-1 activity without transcriptional activation. These compounds reduce tumor cell proliferation, offering potential as therapeutic agents with fewer side effects.
Area of Science:
- Molecular Biology
- Cell Biology
- Pharmacology
Background:
- Retinoids are crucial for biological processes like cell differentiation and proliferation.
- Their therapeutic use is limited by significant side effects.
- Retinoid action is mediated by nuclear receptors (RARs and RXRs) and AP-1 inhibition.
Purpose of the Study:
- To identify conformationally restricted retinoids with selective receptor actions.
- To develop novel retinoid agents with a potentially improved side effect profile.
Main Methods:
- Investigated the distinct mechanisms of retinoid receptor actions.
- Developed and characterized a new class of retinoids.
- Assessed retinoid effects on AP-1 activity, transcriptional activation, F9 cell differentiation, and tumor cell proliferation.
Main Results:
- Identified novel retinoids that selectively inhibit AP-1 activity.
- These retinoids do not activate transcription.
- Demonstrated inhibition of tumor cell proliferation without inducing F9 cell differentiation.
Conclusions:
- A new class of retinoids selectively targets AP-1 signaling.
- These compounds show promise for cancer therapy with potentially reduced side effects.
- Further development could lead to novel therapeutic agents for various conditions.
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Inhibition of CDK Activity
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

